The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lavrenko A.V.

NII geneticheskikh i immunologicheskikh osnov razvitiia patologii i farmakogenetiki Ukrainskoĭ meditsinskoĭ stomatologicheskoĭ akademii, Poltava

Kutsenko N.L.

NII geneticheskikh i immunologicheskikh osnov razvitiia patologii i farmakogenetiki Ukrainskoĭ meditsinskoĭ stomatologicheskoĭ akademii, Poltava

Kutsenko L.A.

NII geneticheskikh i immunologicheskikh osnov razvitiia patologii i farmakogenetiki Ukrainskoĭ meditsinskoĭ stomatologicheskoĭ akademii, Poltava

Mamontova T.V.

NII geneticheskikh i immunologicheskikh osnov razvitiia patologii i farmakogenetiki Ukrainskoĭ meditsinskoĭ stomatologicheskoĭ akademii, Poltava

Kaĭdashev I.P.

NII geneticheskikh i immunologicheskikh osnov razvitiia patologii i farmakogenetiki Ukrainskoĭ meditsinskoĭ stomatologicheskoĭ akademii, Poltava

The action of metformin on the production of pro-inflammatory cytokines and insulin resistance (NF-kB signal pathway)

Authors:

Lavrenko A.V., Kutsenko N.L., Kutsenko L.A., Mamontova T.V., Kaĭdashev I.P.

More about the authors

Journal: Problems of Endocrinology. 2012;58(2): 25‑28

Read: 830 times


To cite this article:

Lavrenko AV, Kutsenko NL, Kutsenko LA, Mamontova TV, Kaĭdashev IP. The action of metformin on the production of pro-inflammatory cytokines and insulin resistance (NF-kB signal pathway). Problems of Endocrinology. 2012;58(2):25‑28. (In Russ.)

Recommended articles:
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
Radionuclide methods in analysis of myocardial perfusion and meta­bolic acti­vity. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):12-19
Reclassification of ischemic heart disease epidemiological criteria. Russian Journal of Preventive Medi­cine. 2024;(12):61-68
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61

References:

  1. De Fronzo R.A. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009; 58: 773-795.
  2. De Fronzo R.A. Insulin resistase, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010; 53: 1270-1287.
  3. Bulcao C., Ribeiro-Filho F.F., Sanudo A. Roberta Ferreira S.G. Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome. Am J Cardiovasc Drugs 2007; 7: 3: 219-224.
  4. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus. Prevocational report of WHO consultation. Diabet Med 1998; 15: 539-553.
  5. Juan M., Ohishi M., Wang L. et al. Association between serum levels of soluble CD40/CD40L ligand and organ damage in hypertensive patients. Clin Exp Pharmacol Physiol 2010; 37: 8: 848-851.
  6. Lutgens E., Levens D., Beckers L. et al. CD40 and its ligand in aterosclerosis. Trends Cardiovasc Med 2007; 17: 4: 118-123.
  7. Lawrens T. The nuclear factor NF-kB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: 6: a001651.
  8. Hattori Y., Suzuki K., Hattori S., Kasal K. Metformin inhibits cytokine-induced nuclear factor kappa B activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006. 47: 6: 1183-1186.
  9. Huang N.L., Chiang S.H., Hsueh C.H. et al. Metformin inhibits TNF-alpha-induced I kappa B kinase phosphorylation, I kappa B alpha degradation and IL-6 production in ebdothelial cells through PI3-dependent AMPK phosphorylation. Int J Cardiol 2009; 134: 2: 169-175.
  10. Wysocki P.J., Wizusz-Wysocka B. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Exp Rev Mol Diagn 2010; 10: 4: 509-519.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.